FDA Announces “National Priority Voucher” Program to Accelerate Reviews of New Drugs

Start
The U.S. Department of Health and Human Services (HHS) and U.S. Food and Drug Administration (FDA) announced on June 17, 2025, the creation of a new initiative called the “Commissioner’s National Priority Voucher” (CNPV) program. Agency leaders have said the program will provide increased communication and a faster regulatory timeline for eligible drugs….
By: Holland & Knight LLP
Previous Story

Employers: A cautionary tale about new cyber threats involving employee handbooks

Next Story

Chambers Guidance: Using AI Large Language Models (LLMs) Wisely and Ethically